Table 3 Classification of participants into three V̇O2peak categories according to measured V̇O2peak and estimated V̇O2peak at baseline and follow-up.
SCG eV̇O2peak | Myers et al. eV̇O2peak | Schembre and Riebe eV̇O2peak | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Lower | Average | Higher | Lower | Average | Higher | Lower | Average | Higher | ||
Baseline V̇O2peak | Lower | 37 (93) | 3 (8) | 0 (0) | 36 (90) | 4 (10) | 0 (0) | 0 (0) | 29 (74) | 10 (26) |
Average | 6 (29) | 15 (71) | 0 (0) | 9 (43) | 12 (57) | 0 (0) | 0 (0) | 5 (26) | 14 (74) | |
Higher | 0 (0) | 4 (67) | 2 (33) | 1 (17) | 5 (83) | 0 (0) | 0 (0) | 1 (17) | 5 (83) | |
Cohen’s Kappa | κ = 0.62 [0.45 to 0.80] | κ = 0.42 [0.23 to 0.61] | κ = − 0.06 [−0.16 to 0.03] | |||||||
Intervention baseline V̇O2peak | Lower | 29 (91) | 3 (9) | 0 (0) | 28 (88) | 4 (13) | 0 (0) | 0 (0) | 24 (80) | 6 (20) |
Average | 5 (33) | 10 (67) | 0 (0) | 7 (47) | 8 (53) | 0 (0) | 0 (0) | 4 (31) | 9 (69) | |
Higher | 0 (0) | 3 (60) | 2 (40) | 1 (20) | 4 (80) | 0 (0) | 0 (0) | 1 (20) | 4 (80) | |
Cohen’s Kappa | κ = 0.58 [0.37 to 0.79] | κ = 0.37 [0.15 to 0.59] | κ = − 0.05 [−0.16 to 0.07] | |||||||
Intervention follow-up V̇O2peak | Lower | 21 (81) | 5 (19) | 0 (0) | 21 (81) | 5 (19) | 0 (0) | 0 (0) | 12 (50) | 12 (50) |
Average | 4 (22) | 11 (61) | 3 (17) | 9 (50) | 9 (50) | 0 (0) | 0 (0) | 6 (35) | 11 (65) | |
Higher | 0 (0) | 2 (25) | 6 (75) | 1 (13) | 7 (88) | 0 (0) | 0 (0) | 0 (0) | 7 (100) | |
Cohen’s Kappa | κ = 0.56 [0.37 to 0.76] | κ = 0.25 [0.04 to 0.45] | κ = 0.06 [−0.05 to 0.17] | |||||||